CanAct® X Solid

Who is it for?

• Patients diagnosed with a metastatic or advanced solid tumour
• Cases where targeted therapy or immunotherapy options are being explored
• Investigation of treatment resistance mechanisms
• Matching to suitable clinical trials

Technical details

Method

DNA + RNA next-generation sequencing (CGP)

Sample

Formalin-fixed, paraffin-embedded (FFPE) tumour tissue

Turnaround time

3–4 weeks

Reported

Point mutations, indels, CNVs, translocations/fusions, MSI, TMB

Variant classification

AMP/ASCO/CAP levels of evidence; FDA and NCCN references

Laboratory

CAP-accredited; certified to ISO 15189, ISO 9001 and ISO 27001

Included with your report

• Clinically actionable biomarkers
• Therapies the tumour may benefit from, and therapies it may be resistant to
• Suitable clinical trials (with NCT numbers)
• MSI status and TMB value
• A physician-friendly report format, with optional counselling

How does the process work?

1. 1
   Leave your request

   Choose the test, or let your physician request it on your behalf. If you are not sure which test fits, we decide together.

2. 2
   We call you

   Our team calls within 1 working day to confirm the request, the sample type (blood or tumour tissue) and your appointment time.

3. 3
   Sample collection

   A blood sample is taken at Akasya Partner Clinics in a few minutes. For tissue tests, the pathology block is collected by courier.

4. 4
   Report and review

   The report is ready in 1–6 weeks depending on the test (stated on each test page), sent to your physician and reviewed with our consultant physicians.